• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院衰弱风险评分对高龄老年患者经导管主动脉瓣置换术后结局的影响

Impact of the Hospital Frailty Risk Score on Outcomes After Transcatheter Aortic Valve Replacement in Late Elderly Patients.

作者信息

Ueki Chikara, Nakatani Eiji, Kaneda Hideaki, Sasaki Hatoko

机构信息

Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, JPN.

Department of Biostatistics and Health Data Science, Graduate School of Medical Science Nagoya City University, Nagoya, JPN.

出版信息

Cureus. 2024 Sep 8;16(9):e68922. doi: 10.7759/cureus.68922. eCollection 2024 Sep.

DOI:10.7759/cureus.68922
PMID:39381490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459420/
Abstract

OBJECTIVES

Prognostic prediction using objective indices is needed to optimize the indications for transcatheter aortic valve replacement (TAVR). We evaluated the impact of the Hospital Frailty Risk Score (HFRS), an International Classification of Diseases (ICD)-based frailty index, on the prognosis after TAVR in the late elderly.

METHODS

We identified patients aged ≥75 years undergoing TAVR from April 2014 to September 2020 from the Shizuoka Kokuho Database (SKDB). Cox logistic regression analysis was performed to examine predictors of long-term mortality. We also evaluated the relationship between HFRS categories (low risk: <5, intermediate risk: 5-15, high risk: >15) and functional decline.

RESULTS

This study involved 607 patients (189 (31.1%) men) with a mean age of 85.0 years. During the median follow-up period of 20 months, survival significantly differed among HFRS categories (survival at two years; low (HFRS <5): 88.9%, intermediate (HFRS 5-15): 82.6%, high (HFRS >15): 67.7%; log-rank p = 0.002). In the multivariate regression model, male sex (hazard ratio (HR): 2.15, 95% confidence interval (CI): 1.42-3.24), preoperative care needs level of ≥3 (HR: 2.43, 95% CI: 1.17-5.06), and HFRS (HR: 1.07, 95% CI: 1.03-1.12) were significant predictors of mortality. Functional decline-free survival significantly differed among HFRS categories (event-free survival at two years; low: 79.4%, intermediate: 75.2%, high: 50.8%; log-rank p = 0.001).

CONCLUSIONS

The HFRS is a predictor of long-term mortality after TAVR in the late elderly and is associated with postoperative functional decline. The HFRS can provide additional information for decision-making regarding treatment strategies for the late elderly.

摘要

目的

需要使用客观指标进行预后预测,以优化经导管主动脉瓣置换术(TAVR)的适应症。我们评估了基于国际疾病分类(ICD)的衰弱指数——医院衰弱风险评分(HFRS)对高龄老年人TAVR术后预后的影响。

方法

我们从静冈国保数据库(SKDB)中确定了2014年4月至2020年9月期间接受TAVR的年龄≥75岁的患者。进行Cox逻辑回归分析以检查长期死亡率的预测因素。我们还评估了HFRS类别(低风险:<5,中度风险:5 - 15,高风险:>15)与功能衰退之间的关系。

结果

本研究纳入了607例患者(189例(31.1%)男性),平均年龄为85.0岁。在20个月的中位随访期内,HFRS类别之间的生存率存在显著差异(两年生存率;低(HFRS <5):88.9%,中度(HFRS 5 - 15):82.6%,高(HFRS >15):67.7%;对数秩检验p = 0.002)。在多变量回归模型中,男性(风险比(HR):2.15,95%置信区间(CI):1.42 - 3.24)、术前护理需求水平≥3(HR:2.43,95% CI:1.17 - 5.06)和HFRS(HR:1.07,95% CI:1.03 - 1.12)是死亡率的显著预测因素。HFRS类别之间无功能衰退的生存率存在显著差异(两年无事件生存率;低:79.4%,中度:75.2%,高:50.8%;对数秩检验p = 0.001)。

结论

HFRS是高龄老年人TAVR术后长期死亡率的预测因素,并且与术后功能衰退相关。HFRS可为高龄老年人治疗策略的决策提供额外信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a024/11459420/013b43beb30a/cureus-0016-00000068922-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a024/11459420/27830e9e2067/cureus-0016-00000068922-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a024/11459420/013b43beb30a/cureus-0016-00000068922-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a024/11459420/27830e9e2067/cureus-0016-00000068922-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a024/11459420/013b43beb30a/cureus-0016-00000068922-i02.jpg

相似文献

1
Impact of the Hospital Frailty Risk Score on Outcomes After Transcatheter Aortic Valve Replacement in Late Elderly Patients.医院衰弱风险评分对高龄老年患者经导管主动脉瓣置换术后结局的影响
Cureus. 2024 Sep 8;16(9):e68922. doi: 10.7759/cureus.68922. eCollection 2024 Sep.
2
Performance of administrative database frailty instruments in predicting clinical outcomes and cost for patients undergoing transcatheter aortic valve implantation: a historical cohort study.基于行政病历数据库的衰弱指标预测行经导管主动脉瓣置换术患者临床结局和成本的效果:一项历史性队列研究。
Can J Anaesth. 2023 Jan;70(1):116-129. doi: 10.1007/s12630-022-02354-6. Epub 2022 Dec 28.
3
Frailty Predicts Adverse Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): From the National Inpatient Sample.衰弱预测老年行经导管主动脉瓣置换术(TAVR)患者的不良结局:来自全国住院患者样本。
Cardiovasc Revasc Med. 2022 Jan;34:56-60. doi: 10.1016/j.carrev.2021.02.004. Epub 2021 Feb 6.
4
Impact of a Claims-Based Frailty Indicator on the Prediction of Long-Term Mortality After Transcatheter Aortic Valve Replacement in Medicare Beneficiaries.基于索赔的衰弱指标对医疗保险受益人群经导管主动脉瓣置换术后长期死亡率预测的影响。
Circ Cardiovasc Qual Outcomes. 2018 Oct;11(10):e005048. doi: 10.1161/CIRCOUTCOMES.118.005048.
5
Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort.全国范围内接受经导管瓣膜治疗的患者的脆弱性及相关结局。
Eur Heart J. 2019 Jul 14;40(27):2231-2239. doi: 10.1093/eurheartj/ehz187.
6
Temporal Changes in Mortality After Transcatheter and Surgical Aortic Valve Replacement: Retrospective Analysis of US Medicare Patients (2012-2019).经导管主动脉瓣置换术和外科主动脉瓣置换术后死亡率的时间变化:美国医疗保险患者的回顾性分析(2012-2019 年)。
J Am Heart Assoc. 2021 Oct 19;10(20):e021748. doi: 10.1161/JAHA.120.021748. Epub 2021 Sep 28.
7
The impact of frailty status on clinical and functional outcomes after transcatheter aortic valve replacement in nonagenarians with severe aortic stenosis.衰弱状态对患有严重主动脉瓣狭窄的非agenarians经导管主动脉瓣置换术后临床和功能结局的影响。 注:这里“nonagenarians”翻译为“九旬老人”更合适,整句译文:衰弱状态对患有严重主动脉瓣狭窄的九旬老人经导管主动脉瓣置换术后临床和功能结局的影响。
Catheter Cardiovasc Interv. 2017 Nov 15;90(6):1000-1006. doi: 10.1002/ccd.27083. Epub 2017 May 2.
8
The Effect and Relationship of Frailty Indices on Survival After Transcatheter Aortic Valve Replacement.衰弱指数对经导管主动脉瓣置换术后生存的影响及关系。
JACC Cardiovasc Interv. 2020 Jan 27;13(2):219-231. doi: 10.1016/j.jcin.2019.08.015.
9
Long-Term Prognosis and Predictors of Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Retrospective Analysis.经导管主动脉瓣置换术患者的长期预后及死亡预测因素:一项回顾性分析
Cureus. 2023 Aug 31;15(8):e44432. doi: 10.7759/cureus.44432. eCollection 2023 Aug.
10
The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: a single-center experience.老年重度主动脉瓣狭窄患者行经导管主动脉瓣置换术后衰弱状况对生存的影响:单中心经验。
JACC Cardiovasc Interv. 2012 Sep;5(9):974-81. doi: 10.1016/j.jcin.2012.06.011.

本文引用的文献

1
Assessment of coding-based frailty algorithms for long-term outcome prediction among older people in community settings: a cohort study from the Shizuoka Kokuho Database.基于编码的衰弱算法对社区老年人长期预后预测的评估:来自静冈国保数据库的队列研究
Age Ageing. 2022 Mar 1;51(3). doi: 10.1093/ageing/afac009.
2
2021 ESC/EACTS Guidelines for the management of valvular heart disease.2021年欧洲心脏病学会/欧洲心胸外科学会瓣膜性心脏病管理指南。
Eur Heart J. 2022 Feb 12;43(7):561-632. doi: 10.1093/eurheartj/ehab395.
3
Frailty Predicts Adverse Outcomes in Older Patients Undergoing Transcatheter Aortic Valve Replacement (TAVR): From the National Inpatient Sample.
衰弱预测老年行经导管主动脉瓣置换术(TAVR)患者的不良结局:来自全国住院患者样本。
Cardiovasc Revasc Med. 2022 Jan;34:56-60. doi: 10.1016/j.carrev.2021.02.004. Epub 2021 Feb 6.
4
Data Resource Profile of Shizuoka Kokuho Database (SKDB) Using Integrated Health- and Care-insurance Claims and Health Checkups: The Shizuoka Study.静冈国民健康保险组合与健康检查组合数据库(SKDB)的数据资源概况:静冈研究。
J Epidemiol. 2022 Aug 5;32(8):391-400. doi: 10.2188/jea.JE20200480. Epub 2021 Jul 17.
5
Validating care-needs level against self-reported measures of functioning, disability and sarcopenia among Japanese patients receiving home medical care: The Zaitaku Evaluative Initiatives and Outcome Study.验证接受家庭医疗护理的日本患者的自理能力、残疾和肌肉减少症的自我报告测量结果与护理需求水平的相关性:Zaitaku 评估计划和结果研究。
Geriatr Gerontol Int. 2021 Feb;21(2):229-237. doi: 10.1111/ggi.14124. Epub 2021 Jan 3.
6
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2020 ACC/AHA 瓣膜性心脏病患者管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南联合委员会的报告。
J Am Coll Cardiol. 2021 Feb 2;77(4):450-500. doi: 10.1016/j.jacc.2020.11.035. Epub 2020 Dec 17.
7
Impact of Frailty on Mortality, Readmissions, and Resource Utilization After TAVI.经导管主动脉瓣置换术(TAVI)后衰弱对死亡率、再入院率和资源利用的影响。
Am J Cardiol. 2020 Jul 15;127:120-127. doi: 10.1016/j.amjcard.2020.03.047. Epub 2020 Apr 24.
8
Frailty and related outcomes in patients undergoing transcatheter valve therapies in a nationwide cohort.全国范围内接受经导管瓣膜治疗的患者的脆弱性及相关结局。
Eur Heart J. 2019 Jul 14;40(27):2231-2239. doi: 10.1093/eurheartj/ehz187.
9
Evaluation of Changes in Functional Status in the Year After Aortic Valve Replacement.主动脉瓣置换术后 1 年功能状态变化的评估。
JAMA Intern Med. 2019 Mar 1;179(3):383-391. doi: 10.1001/jamainternmed.2018.6738.
10
External validation of the Hospital Frailty Risk Score and comparison with the Hospital-patient One-year Mortality Risk Score to predict outcomes in elderly hospitalised patients: a retrospective cohort study.医院衰弱风险评分的外部验证及与医院-患者一年死亡率风险评分的比较,以预测老年住院患者的结局:一项回顾性队列研究。
BMJ Qual Saf. 2019 Apr;28(4):284-288. doi: 10.1136/bmjqs-2018-008661. Epub 2018 Oct 31.